(IBTK) iShares iBonds Dec 2030 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E5933

Treasury Securities, Cash, Cash Equivalents, Short-Term Paper

Description: IBTK iShares iBonds Dec 2030

The iShares iBonds Dec2030 Term Treasury ETF (NASDAQ:IBTK) is a target maturity ETF that tracks the ICE2030 Maturity U.S. Treasury Index, investing in U.S. Treasury securities maturing between January 1, 2030, and December 15, 2030. This provides investors with a predictable income stream and a relatively low-risk investment option.

From a portfolio management perspective, the ETFs investment strategy is straightforward, focusing on holding individual U.S. Treasury securities until maturity, thereby minimizing credit risk. The fund may also hold short-term paper, cash, and cash equivalents to manage liquidity. With an AUM of $435.94M, the ETF has a moderate size, which is sufficient to provide liquidity but not so large that it becomes unwieldy.

Key Performance Indicators (KPIs) to monitor for IBTK include yield to maturity (YTM), duration, and the average credit quality of the holdings. Given the ETFs focus on U.S. Treasury securities, credit quality is extremely high, effectively risk-free. The YTM will be a critical metric, as it reflects the total return an investor can expect if holding the ETF until the underlying securities mature. Duration, which measures sensitivity to interest rate changes, is also crucial, as it will be relatively high given the ETFs long maturity profile.

Investors should also consider the ETFs expense ratio, trading volume, and bid-ask spread as KPIs. A low expense ratio, high trading volume, and tight bid-ask spread are desirable, as they indicate lower costs and higher liquidity, making it easier to enter or exit positions without significantly affecting the price.

IBTK ETF Overview

Market Cap in USD 512m
Category Target Maturity
TER 0.07%
IPO / Inception 2020-07-14

IBTK ETF Ratings

Growth Rating 37.4%
Fundamental -
Dividend Rating 72.7%
Return 12m vs S&P 500 -13.5%
Analyst Rating -

IBTK Dividends

Dividend Yield 12m 3.55%
Yield on Cost 5y 3.16%
Annual Growth 5y 63.77%
Payout Consistency 100.0%
Payout Ratio %

IBTK Growth Ratios

Growth Correlation 3m 87.7%
Growth Correlation 12m 75.5%
Growth Correlation 5y -6.8%
CAGR 5y 3.23%
CAGR/Max DD 3y 0.38
CAGR/Mean DD 3y 1.46
Sharpe Ratio 12m -0.95
Alpha -18.08
Beta 0.978
Volatility 4.13%
Current Volume 156.6k
Average Volume 20d 104.7k
Stop Loss 19.3 (-3.2%)
Signal -0.34

What is the price of IBTK shares?

As of September 13, 2025, the stock is trading at USD 19.93 with a total of 156,591 shares traded.
Over the past week, the price has changed by -0.08%, over one month by +1.18%, over three months by +2.57% and over the past year by +2.99%.

Is iShares iBonds Dec 2030 a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, iShares iBonds Dec 2030 (NASDAQ:IBTK) is currently (September 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 37.40 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTK is around 18.76 USD . This means that IBTK is currently overvalued and has a potential downside of -5.87%.

Is IBTK a buy, sell or hold?

iShares iBonds Dec 2030 has no consensus analysts rating.

What are the forecasts/targets for the IBTK price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.1 6%

Last update: 2025-09-06 04:40

IBTK Fundamental Data Overview

Market Cap USD = 512.1m (512.1m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 1.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 512.1m USD (512.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 512.1m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 512.1m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(512.1m)/V(0.0) * Re(9.62%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.62% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBTK ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle